VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells. 2022

Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
School of Medical and Life Sciences, Escola de Ciências Médicas e da Vida, Pontifícia Universidade Católica de Goiás (PUC GOIÁS), Avenida Universitária 1.440, Setor Universitário, Goiânia, GO, 74605-010, Brazil. melocruvinel@gmail.com.

The VI Brazilian Consensus on Autoantibodies against HEp-2 cells for determination of autoantibodies against cellular constituents on HEp-2 cells was held on September, 2019, in Fortaleza (CE, Brazil). The guidelines in this edition were formulated by the group of Brazilian experts discussing the classification of complex patterns, the classification of the nuclear discrete dots (few and multiple), the identification of the discrete fine speckled pattern (AC-4a) and improvements on the ANA report. Sixteen Brazilian researchers and experts from universities and clinical laboratories representing the various geographical regions of Brazil participated in the meeting. Four main topics were discussed: (1) How to classify patterns with fluorescence in more than one cell compartment considering three relevant categoris: composite patterns, mixed patterns and multiple patterns; (2) The splitting of the discrete nuclear dots pattern into the multiple discrete nuclear dots (AC-6) and few discrete nuclear dots (AC-7) patterns, respectively; (3) Inclusion of a novel nuclear pattern characterized by discrete fine speckled pattern highly associated with antibodies to SS-A/Ro60, classified as AC-4a. In addition, adjustments on the Brazilian Consensus nomenclature were implemented aiming to harmonize the designation of some patterns with the International Consensus on ANA Patterns (ICAP). Furthermore, the designations of the PCNA-like pattern (AC-13), CENP-F-like pattern (AC-14) and Topo I-like pattern (AC-29) were adjusted in accordance to ICAP. Finally, there was a recommendation for adjustment in the test report in order to address the status of nuclear envelope staining. For all topics, the aim was to establish specific guidelines for laboratories and clinicians. All recommendations were based on consensus among participants. All recommendations from the V Consensus were maintained and there was relevant progress in the BCA/HEp-2 guidelines and further harmonization with ICAP. The VI BCA/HEp-2 edition was successful in establishing important recommendations regarding the classification of complex patterns, in supporting the identification of a novel pattern within the AC-4 group and in the harmonization process with the ICAP terminology.

UI MeSH Term Description Entries
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D032921 Consensus General agreement or collective opinion; the judgment arrived at by most of those concerned. Consensus Development,Development, Consensus

Related Publications

Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
January 2019, Methods in molecular biology (Clifton, N.J.),
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
January 2023, Frontiers in immunology,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
January 1986, Diagnostic immunology,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
July 2010, Arquivos brasileiros de cardiologia,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
January 2012, Clinical & developmental immunology,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
September 2009, Annals of the New York Academy of Sciences,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
June 2009, Deutsche medizinische Wochenschrift (1946),
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
October 2014, Oncoimmunology,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
May 1989, Rinsho byori. The Japanese journal of clinical pathology,
Wilson de Melo Cruvinel, and Luis Eduardo Coelho Andrade, and Alessandra Dellavance, and Antônio Carlos Ximenes, and Carlos David Araújo Bichara, and Cristóvão Luis Pitangueira Mangueira, and Eloísa Bonfá, and Fabiano de Almeida Brito, and Henrique Ataíde Mariz, and Lisiane Maria Enriconi Dos Anjos, and Sandra Gofinet Pasoto, and Valeria Valim, and Wilton Ferreira Silva Dos Santos, and Clayson Moura Gomes, and Roberpaulo Anacleto Neves, and Paulo Luiz Carvalho Francescantonio
February 2023, Clinical chemistry and laboratory medicine,
Copied contents to your clipboard!